Gene · 6249
Papers2,568
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,568
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of early life gut resistome and mobilome across gestational ages and microbiota-modifying treatments. | EBioMedicine | 2023 | 37187112 | PubTator, text mining | PubMed |
| The Potential of Cylindromatosis (CYLD) as a Therapeutic Target in Oxidative Stress-Associated Pathologies: A Comprehensive Evaluation. | Int J Mol Sci | 2023 | 37176077 | PubTator, text mining | PubMed |
| CLEC16A-An Emerging Master Regulator of Autoimmunity and Neurodegeneration. | Int J Mol Sci | 2023 | 37175930 | PubTator, text mining | PubMed |
| cis-B7:CD28 interactions at invaginated synaptic membranes provide CD28 co-stimulation and promote CD8+ T cell function and anti-tumor immunity. | Immunity | 2023 | 37160118 | PubTator, text mining | PubMed |
| An mRNA processing pathway suppresses metastasis by governing translational control from the nucleus. | Nat Cell Biol | 2023 | 37156909 | PubTator, text mining | PubMed |
| An immunoinformatic approach to assessing the immunogenic capacity of alpha-neurotoxins in elapid snake venoms. | Front Pharmacol | 2023 | 37153801 | PubTator, text mining | PubMed |
| Matching single cells across modalities with contrastive learning and optimal transport. | Brief Bioinform | 2023 | 37122067 | PubTator, text mining | PubMed |
| Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer. | Pharmaceutics | 2023 | 37111737 | PubTator, text mining | PubMed |
| Natural Products as New Approaches for Treating Bladder Cancer: From Traditional Medicine to Novel Drug Discovery. | Pharmaceutics | 2023 | 37111603 | PubTator, text mining | PubMed |
| Antagonistic Interactions in Mitochondria ROS Signaling Responses to Manganese. | Antioxidants (Basel) | 2023 | 37107179 | PubTator, text mining | PubMed |
| Tubulin Post-Translational Modifications: The Elusive Roles of Acetylation. | Biology (Basel) | 2023 | 37106761 | PubTator, text mining | PubMed |
| Long non-coding RNAs as critical regulators and novel targets in cervical cancer: current status and future perspectives. | Apoptosis | 2023 | 37095313 | PubTator, text mining | PubMed |
| The motor domain of the kinesin Kip2 promotes microtubule polymerization at microtubule tips. | J Cell Biol | 2023 | 37093124 | PubTator, text mining | PubMed |
| Basement membrane-related regulators for prediction of prognoses and responses to diverse therapies in hepatocellular carcinoma. | BMC Med Genomics | 2023 | 37081465 | PubTator, text mining | PubMed |
| Visualizing the Nucleome Using the CRISPR-Cas9 System: From in vitro to in vivo. | Biochemistry (Mosc) | 2023 | 37069118 | PubTator, text mining | PubMed |
| Coordination between the Ndc80 complex and dynein is essential for microtubule plus-end capture by kinetochores during early mitosis. | J Biol Chem | 2023 | 37060995 | PubTator, text mining | PubMed |
| A cell-free antigen processing system informs HIV-1 epitope selection and vaccine design. | J Exp Med | 2023 | 37058141 | PubTator, text mining | PubMed |
| BI-D1870 Induces Mitotic Dysfunction and Apoptosis in Neuroblastoma by Regulating the PI3K-Akt-mTORC1 Signal Axis. | Cancers (Basel) | 2023 | 37046682 | PubTator, text mining | PubMed |
| Small vault RNA1-2 modulates expression of cell membrane proteins through nascent RNA silencing. | Life Sci Alliance | 2023 | 37037596 | PubTator, text mining | PubMed |
| Small extracellular vesicles promote invadopodia activity in glioblastoma cells in a therapy-dependent manner. | Cell Oncol (Dordr) | 2023 | 37014551 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6249/papers?page=12